Results 21 to 30 of about 2,997,892 (269)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

Biomolecules, 2020
The potential therapeutic use of some Cannabis sativa plant compounds has been attracting great interest, especially for managing neuropsychiatric disorders due to the relative lack of efficacy of the current treatments.
M. García-Gutiérrez, F. Navarrete, A. Gasparyan, Amaya Austrich-Olivares, F. Sala, J. Manzanares   +5 more
semanticscholar   +1 more source

Schizophrenia and Other Psychotic Disorders

Definitions, 2020
The disorders in this section include Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Delusional Disorder, Brief Psychotic Disorder, Shared Psychotic Disorder, Psychotic Disorder Due to a General Medical Condition, SubstanceInduced ...
David A. Wilder, Stephen E. Wong, Ansley C. Hodges, H. Ertel   +3 more
semanticscholar   +1 more source

White Matter Measures and Cognition in Schizophrenia

Frontiers in Psychiatry, 2020
White matter (WM) abnormalities are commonly reported in schizophrenia but whether these arise from the axon or myelin compartments or both is not known.
Cemre Erkol, Talia Cohen, Virginie-Anne Chouinard, Virginie-Anne Chouinard, Kathryn Eve Lewandowski, Kathryn Eve Lewandowski, Fei Du, Fei Du, Dost Öngür, Dost Öngür   +9 more
doaj   +1 more source

RNA-seq co-expression network analysis reveals anxiolytic behavior of mice with Efnb2 knockout in parvalbumin+ neurons

Molecular Brain, 2021
Anxiety disorders are the most common psychiatric disorders, and the change in the activity of the prefrontal cortex (PFC) is considered as the underlying pathological mechanism. Parvalbumin-expressing (PV+) inhibition contributes to the overall activity
Ying Sun, Le Ma, Jianhua Chen, Weidi Wang, Shiyu Peng, Ying Cheng, Yu Zhang, Jinghong Chen, Peijun Ju   +8 more
doaj   +1 more source

Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.

Schizophrenia bulletin, 2020
Ischemic heart disease is the leading cause of mortality in psychotic disorders. There is a paucity of research comprehensively evaluating short-term mortality, cardiovascular complications, and treatment inequality after cardiac events in patients with ...
W. Chang, J. K. N. Chan, C. Wong, JoJo Hai, P. C. F. Or, E. Chen   +5 more
semanticscholar   +1 more source

Nightmares in Patients with Major Depressive Disorder, Bipolar Disorder, and Psychotic Disorders: A Systematic Review

Journal of Clinical Medicine, 2020
Chronic nightmares are very common in psychiatric disorders, affecting up to 70% of patients with personality or post-traumatic stress disorders. In other psychiatric disorders, the relationships with nightmares are poorly known.
M. A. Akkaoui, M. Lejoyeux, M. d’Ortho, P. Geoffroy   +3 more
semanticscholar   +1 more source

Aggression among 216 patients with a first-psychotic episode of bipolar I disorder

International Journal of Bipolar Disorders, 2018
Background Aggression by patients with bipolar I disorder (BD-I) is not uncommon. Identifying potential risk factors early in the illness-course should inform clinical management and reduce risk.
Hari-Mandir K. Khalsa, Ross J. Baldessarini, Mauricio Tohen, Paola Salvatore   +3 more
doaj   +1 more source

Living arrangement modifies the associations of loneliness with adverse health outcomes in older adults: evidence from the CLHLS

BMC Geriatrics, 2022
Background Although it has been suggested that loneliness is a risk factor for adverse health outcomes, living arrangement may confound the association.
Kai Wei, Yong Liu, Junjie Yang, Nannan Gu, Xinyi Cao, Xudong Zhao, Lijuan Jiang, Chunbo Li   +7 more
doaj   +1 more source

Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept

International Journal of Bipolar Disorders, 2022
Objective To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2). Methods We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly ...
Leonardo Tondo, Alessandro Miola, Marco Pinna, Martina Contu, Ross J. Baldessarini   +4 more
doaj   +1 more source

Comparing the efficacies of transcranial magnetic stimulation treatments using different targeting methods in major depressive disorder: protocol for a network meta-analysis

BMJ Open, 2023
Introduction Transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (lDLPFC) has been widely used as a treatment for major depressive disorder (MDD) in the past two decades. Different methods for localising the lDLPFC target
Hui Li, Jijun Wang, Huiru Cui, Lihua Xu, Yingying Tang, Jingjing Huang, Junjie Wang, Zhenying Qian, Sirui Wang, Gai Kong, Guanfu Wu, Yumei Wei   +11 more
doaj   +1 more source